References
- Filippi E, Staughton J, Peregrine E, et al. Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening. Ultrasound Obstet Gynecol 2011;37:520–7
- Duric K, Skrablin S, Lesin J, et al. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol 2003;110:12–5
- Roberge S, Giguere Y, Villa P, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia. Am J Perinatol 2012;29:551–6
- Bujold E, Roberg S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–14
- Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomised controlled clinical trial. Croat Med J 2005;46:826–31
- Duley L, Henderson-Smart D, Meher S, King J. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev2007: DOI: 10.1002/14651858.CD14004659.pub14651852
- Kafkasli A, Turkcuoglu I, Turhan U. Maternal, fetal and perinatal characteristics of preeclampsia cases with and without abnormalities in uterine artery Doppler indexes. J Matern Fetal Neonatal Med 2013;26:936–40
- Sagol S, Ozkinay E, Oztekin K, Ozdemir N. The comparison of uterine artery Doppler velocimetry with the histopathology of the placental bed. Aust N Z J Obstet Gynaecol 1999;39:324–9
- Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Physician 2009;80:1371–8
- Proctor LK, Toal M, Keating S, et al. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2009;34:274–82
- Vythilingum B, Geerts L, Fincham D, et al. Association between antenatal distress and uterine artery pulsatility index. Arch Womens Ment Health 2010;13:359–64
- Ay E, Kavak ZN, Elter K, et al. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Aust N Z J Obstet Gynaecol 2005;45:283–8
- Cunningham FG, Leveno KJ, Bloom SL, et al. Obstetrical complications. In: Cunningham F, Gary MD, eds. Williams Obstetrics. 23th ed. New York: Mc Graw Hill; 2010. pp 843
- Roberge S, Villa P, Nicolaides K, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012;31:141–6
- Roberge S, Nicolaides K, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013;41:491–9
- Maher JE, Owen J, Hauth J, et al. The effect of low-dose aspirin on fetal urine output and amniotic fluid volume. Am J Obstet Gynecol 1993;169:885–8
- Gris JC, Mercier E, Quere I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695–9
- Papageorghiou AT, Yu CK, Bindra R, et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441–9
- Bujold E, Morency AM, Roberge S, et al. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009;31:818–26